Skip to content

维拉治疗

US · VERA #2739 按市值排名 上市于 2021
27.88 -0.69 -2.42%
实时 - 追踪5344个代码 - 心跳于145秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了4家。
  • 机构持股总比例下降了1.7个百分点。

机构持股

机构持股比例
117.15% -1.68pp
机构数量
266 -4
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund55.16%
Hedge Fund34.91%
VC/PE Fund18.59%
Public Company7.28%
Individual/Insider0.89%
Private Company0.84%
Government Pension Fund0.26%

主要股东 截至 2026-06-30

BlackRock 7.98% · 5.75M 股
Avoro Capital Advisors LLC 7.94% · 5.72M 股
Longitude Capital Management Co., LLC 7.49% · 5.39M 股
State Street Global Advisors 5.76% · 4.15M 股
T. Rowe Price Group, Inc. 5.57% · 4.01M 股
Deep Track Capital, LP 5.55% · 4.00M 股
Deerfield Management Company, L.P. 5.43% · 3.92M 股
Vanguard Capital Management, LLC 4.47% · 3.22M 股
Kynam Capital Management, LP 4.01% · 2.89M 股
Sofinnova Investments, Inc. 3.88% · 2.79M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 31次买入 · 16次卖出

姓名职务持股比例
Marshall Fordyce Chief Executive Officer 0.40%
Beth Seidenberg Independent Director 0.19%
Sean Grant Chief Financial Officer 0.09%
Joseph Young Senior VP of Finance & Chief Accounting Officer 0.07%
Jason Carter Chief Legal Officer 0.07%
Andrew Cheng Independent Director 0.02%
Laurence Skelton -- 0.01%
Robert Brenner Chief Medical Officer 0.01%
David Johnson Chief Opearating Officer 0.01%
Patrick Gerald Enright Independent Director 0.01%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-14 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $2.90–37.00
2026-09-10 Joseph Young Senior VP of Finance & Chief Accounting Officer Derivative Exercise and Retained +5,000 $3.94
2026-09-01 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $2.90–35.12
2026-08-02 Nancy Boman -- Other Acquisition +44,987 --
2026-08-02 Nancy Boman -- Other Derivative Acquisition +63,011 $32.23
2026-07-06 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -46,250 $2.90–43.59
2026-06-22 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $2.90–38.43
2026-05-20 Michael Morrissey Independent Chairperson Other Derivative Acquisition +17,084 $34.35
2026-05-20 Patrick Gerald Enright Independent Director Other Derivative Acquisition +17,084 $34.35
2026-05-20 Beth Seidenberg Independent Director Other Derivative Acquisition +17,084 $34.35
2026-05-20 Scott William Morrison Independent Director Other Derivative Acquisition +17,084 $34.35
2026-05-20 James Meyers Director Other Derivative Acquisition +17,084 $34.35
2026-05-20 Andrew Cheng Independent Director Other Derivative Acquisition +17,084 $34.35
2026-05-20 Christy Oliger Director Other Derivative Acquisition +17,084 $34.35
2026-05-20 Kimball Hall -- Other Derivative Acquisition +17,084 $34.35
2026-05-11 Marshall Fordyce Chief Executive Officer Derivative Exercise and Sale -18,500 $2.90–37.09
2026-04-13 Marshall Fordyce Chief Executive Officer Automatic Disposition -22,951 $43.66–45.51
2026-03-22 Jane Wright-Mitchell Chief Legal Officer Other Acquisition +42,403 --
2026-03-22 Jane Wright-Mitchell Chief Legal Officer Other Derivative Acquisition +56,850 $40.73
2026-03-12 Joseph Young Senior VP of Finance & Chief Accounting Officer Derivative Exercise and Retained +10,000 $3.94

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

维拉治疗 讨论区 0 条评论

发表评论